Protein Description

Gene Symbol ITGB3
Entrez ID 3690
Uniprot ID P05106
Description integrin subunit beta 3
Chromosomal Location chr17: 47,253,846-47,311,816
Ontology GO ID GO Term Definition Evidence

BP

GO:0001934

positive regulation of protein phosphorylation

Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.

TAS

BP

GO:0001938

positive regulation of endothelial cell proliferation

Any process that activates or increases the rate or extent of endothelial cell proliferation.

IMP

BP

GO:0002576

platelet degranulation

The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.

TAS

BP

GO:0007044

cell-substrate junction assembly

The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.

IEA

BP

GO:0007155

cell adhesion

The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.

TAS

BP

GO:0007160

cell-matrix adhesion

The binding of a cell to the extracellular matrix via adhesion molecules.

IDA|IMP

BP

GO:0007229

integrin-mediated signaling pathway

A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IDA|TAS

BP

GO:0007596

blood coagulation

The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.

TAS

BP

GO:0010595

positive regulation of endothelial cell migration

Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.

IMP

BP

GO:0010745

negative regulation of macrophage derived foam cell differentiation

Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.

IMP

BP

GO:0010888

negative regulation of lipid storage

Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.

IMP

BP

GO:0014909

smooth muscle cell migration

The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism.

IMP

BP

GO:0016049

cell growth

The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.

IMP

BP

GO:0016477

cell migration

The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.

IMP

BP

GO:0030168

platelet activation

A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.

IMP

BP

GO:0030198

extracellular matrix organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.

TAS

BP

GO:0030949

positive regulation of vascular endothelial growth factor receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.

TAS

BP

GO:0031589

cell-substrate adhesion

The attachment of a cell to the underlying substrate via adhesion molecules.

IMP

BP

GO:0032147

activation of protein kinase activity

Any process that initiates the activity of an inactive protein kinase.

IMP

BP

GO:0032369

negative regulation of lipid transport

Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IMP

BP

GO:0033627

cell adhesion mediated by integrin

The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.

IDA

BP

GO:0034113

heterotypic cell-cell adhesion

The attachment of a cell to a cell of a different type via adhesion molecules.

IMP

BP

GO:0034446

substrate adhesion-dependent cell spreading

The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.

IDA

BP

GO:0035295

tube development

The process whose specific outcome is the progression of a tube over time, from its initial formation to a mature structure. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues including lung and trachea, kidney, the mammary gland, the vascular system and the gastrointestinal and urinary-genital tracts.

TAS

BP

GO:0038027

apolipoprotein A-I-mediated signaling pathway

A series of molecular signals initiated by the binding of apolipoprotein A-I to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IMP

BP

GO:0042060

wound healing

The series of events that restore integrity to a damaged tissue, following an injury.

IC

BP

GO:0045124

regulation of bone resorption

Any process that modulates the frequency, rate or extent of bone tissue loss (resorption).

TAS

BP

GO:0045715

negative regulation of low-density lipoprotein particle receptor biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of low-density lipoprotein particle receptors.

IMP

BP

GO:0046718

viral entry into host cell

The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.

IMP

BP

GO:0048010

vascular endothelial growth factor receptor signaling pathway

Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.

TAS

BP

GO:0048333

mesodermal cell differentiation

The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.

IEP

BP

GO:0050731

positive regulation of peptidyl-tyrosine phosphorylation

Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.

IMP

BP

GO:0050748

negative regulation of lipoprotein metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids.

IMP

BP

GO:0050900

leukocyte migration

The movement of a leukocyte within or between different tissues and organs of the body.

TAS

BP

GO:0050919

negative chemotaxis

The directed movement of a motile cell or organism towards a lower concentration of a chemical.

IMP

BP

GO:0060055

angiogenesis involved in wound healing

Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury.

TAS

BP

GO:0070527

platelet aggregation

The adhesion of one platelet to one or more other platelets via adhesion molecules.

IMP

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

IDA|TAS

CC

GO:0005887

integral component of plasma membrane

The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

TAS

CC

GO:0005925

focal adhesion

Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.

IDA

CC

GO:0008305

integrin complex

A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands.

IDA

CC

GO:0009986

cell surface

The external part of the cell wall and/or plasma membrane.

IDA

CC

GO:0031092

platelet alpha granule membrane

The lipid bilayer surrounding the platelet alpha granule.

TAS

CC

GO:0031258

lamellipodium membrane

The portion of the plasma membrane surrounding a lamellipodium.

IDA

CC

GO:0031527

filopodium membrane

The portion of the plasma membrane surrounding a filopodium.

IDA

CC

GO:0031528

microvillus membrane

The portion of the plasma membrane surrounding a microvillus.

IDA

CC

GO:0032587

ruffle membrane

The portion of the plasma membrane surrounding a ruffle.

IDA

CC

GO:0034683

integrin alphav-beta3 complex

An integrin complex that comprises one alphav subunit and one beta3 subunit.

IDA

CC

GO:0035867

alphav-beta3 integrin-IGF-1-IGF1R complex

A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits.

IDA

CC

GO:0042470

melanosome

A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.

IDA

CC

GO:0043235

receptor complex

Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IDA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

CC

GO:0071062

alphav-beta3 integrin-vitronectin complex

A protein complex that consists of an alphav-beta3 integrin complex bound to vitronectin.

TAS

MF

GO:0001618

virus receptor activity

Combining with a virus component and mediating entry of the virus into the cell.

IEA

MF

GO:0001968

fibronectin binding

Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.

IMP

MF

GO:0002020

protease binding

Interacting selectively and non-covalently with any protease or peptidase.

IDA

MF

GO:0003756

protein disulfide isomerase activity

Catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins.

IDA

MF

GO:0005161

platelet-derived growth factor receptor binding

Interacting selectively and non-covalently with the platelet-derived growth factor receptor.

TAS

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0015026

coreceptor activity

Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.

TAS

MF

GO:0017134

fibroblast growth factor binding

Interacting selectively and non-covalently with a fibroblast growth factor.

IDA

MF

GO:0019899

enzyme binding

Interacting selectively and non-covalently with any enzyme.

IPI

MF

GO:0019960

C-X3-C chemokine binding

Interacting selectively and non-covalently with a C-X3-C chemokine; C-X3-C chemokines have three amino acids between the first two cysteines of the characteristic four-cysteine motif.

IDA

MF

GO:0031994

insulin-like growth factor I binding

Interacting selectively and non-covalently with insulin-like growth factor I.

IDA

MF

GO:0038132

neuregulin binding

Interacting selectively and non-covalently with a neuregulin, a member of the EGF family of growth factors.

IDA

MF

GO:0042802

identical protein binding

Interacting selectively and non-covalently with an identical protein or proteins.

IPI

MF

GO:0043184

vascular endothelial growth factor receptor 2 binding

Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2.

IPI|TAS

MF

GO:0050839

cell adhesion molecule binding

Interacting selectively and non-covalently with a cell adhesion molecule.

IPI

MF

GO:0050840

extracellular matrix binding

Interacting selectively and non-covalently with a component of the extracellular matrix.

IDA

Domain ID Description

IPR002035

von Willebrand factor, type A

IPR002369

Integrin beta subunit, VWA domain

IPR012896

Integrin beta subunit, tail

IPR013111

EGF-like domain, extracellular

IPR014836

Integrin beta subunit, cytoplasmic domain

IPR015812

Integrin beta subunit

IPR016201

PSI domain

IPR027068

Integrin beta-3 subunit

IPR032695

Integrin domain

IPR033760

Integrin beta N-terminal

Pathway ID Pathway Term Pathway Source

hsa04015

Rap1 signaling pathway

KEGG

hsa04145

Phagosome

KEGG

hsa04151

PI3K-Akt signaling pathway

KEGG

hsa04380

Osteoclast differentiation

KEGG

hsa04510

Focal adhesion

KEGG

hsa04512

ECM-receptor interaction

KEGG

hsa04611

Platelet activation

KEGG

hsa04640

Hematopoietic cell lineage

KEGG

hsa04810

Regulation of actin cytoskeleton

KEGG

hsa04919

Thyroid hormone signaling pathway

KEGG

hsa05205

Proteoglycans in cancer

KEGG

hsa05206

MicroRNAs in cancer

KEGG

hsa05410

Hypertrophic cardiomyopathy (HCM)

KEGG

hsa05412

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

KEGG

hsa05414

Dilated cardiomyopathy

KEGG

hsa05418

Fluid shear stress and atherosclerosis

KEGG

WP2849

Hematopoietic Stem Cell Differentiation

WikiPathways

WP306

Focal Adhesion

WikiPathways

WP2572

Primary Focal Segmental Glomerulosclerosis FSGS

WikiPathways

WP366

TGF-beta Signaling Pathway

WikiPathways

WP1455

Serotonin Transporter Activity

WikiPathways

WP2118

Arrhythmogenic Right Ventricular Cardiomyopathy

WikiPathways

WP3301

MFAP5-mediated ovarian cancer cell motility and invasiveness

WikiPathways

WP185

Integrin-mediated Cell Adhesion

WikiPathways

WP322

Osteoblast Signaling

WikiPathways

WP1434

Osteopontin Signaling

WikiPathways

WP12

Osteoclast Signaling

WikiPathways

WP3932

Focal Adhesion-PI3K-Akt-mTOR-signaling pathway

WikiPathways

WP727

Monoamine Transport

WikiPathways

WP3888

VEGFA-VEGFR2 Signaling Pathway

WikiPathways

h_edg1Pathway

Phospholipids as signalling intermediaries

BioCarta

h_ucalpainPathway

uCalpain and friends in Cell spread

BioCarta

UMLS CUI UMLS Term

C0004352

Autistic Disorder

C0007274

Carotid Artery Thrombosis

C0008074

Child Development Disorders, Pervasive

C0010072

Coronary Thrombosis

C0017639

Gliosis

C0019080

Hemorrhage

C0027051

Myocardial Infarction

C0031117

Peripheral Neuropathy

C0033578

Prostatic Neoplasms

C0038454

Cerebrovascular Accident

C0040015

Thrombasthenia

C0040034

Thrombocytopenia

C0948089

Acute Coronary Syndrome

C2937358

Cerebral Hemorrhage

C3853779

Neonatal Alloimmune Thrombocytopenia

Tissue Cell Type

bone marrow

hematopoietic cells

Database Name

DisGeNET

DGA

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

Gene Symbol Entrez ID Uniprot ID Score

TNC

3371

P24821

0.00

LAMA3

3909

Q16787

0.00

LAMA5

3911

O15230

0.00

LAMB1

3912

P07942

0.00

LAMC1

3915

P11047

0.00

LAMC2

3918

Q13753

0.00

PRKCG

5582

P05129

0.00

SPP1

6696

P10451

0.00

TNR

7143

Q92752

0.00

VASP

7408

P50552

0.00

PARVB

29780

Q9HBI1

0.00

PARVA

55742

Q9NVD7

0.00

PARVG

64098

Q9HBI0

0.00

FBLN2

2199

P98095

0.52

FGA

2243

P02671

0.52

FGG

2266

P02679

0.52

VWF

7450

P04275

0.52

COL1A2

1278

P08123

0.55

SHC1

6464

P29353

0.55

P4HB

5034

P07237

0.56

RGS12

6002

O14924

0.56

MAPK8IP1

9479

Q9UQF2

0.56

RABGAP1

23637

Q9Y3P9

0.56

GULP1

51454

Q9UBP9

0.56

ANKS1B

56899

Q7Z6G8

0.56

PECAM1

5175

P16284

0.58

FN1

2335

P02751

0.62

EPHA2

1969

P29317

0.63

PTPN11

5781

Q06124

0.63

SYK

6850

P43405

0.63

NID1

4811

P14543

0.65

PTPRZ1

5803

P23471

0.65

VTN

7448

P04004

0.65

PTPN1

5770

P18031

0.72

PDGFRB

5159

P09619

0.74

CIB1

10519

Q99828

0.77

ITGA5

3678

P08648

0.83

ITGB3

3690

P05106

0.85

ACTN4

81

O43707

0.00

ACTN1

87

P12814

0.00

CAV1

857

Q03135

0.00

CAV2

858

P51636

0.00

CAV3

859

P56539

0.00

CHAD

1101

O15335

0.00

COL1A1

1277

P02452

0.00

COL2A1

1280

P02458

0.00

COL4A2

1284

P08572

0.00

COL4A5

1287

P29400

0.00

COL5A1

1289

P20908

0.00

COL6A1

1291

P12109

0.00

CRK

1398

P46108

0.00

CRKL

1399

P46109

0.00

FLNC

2318

Q14315

0.00

BCAR1

9564

P56945

0.00

COL5A3

50509

P25940

0.00

AKT1

207

P31749

0.52

KDR

3791

P35968

0.52

PDPK1

5170

O15530

0.52

ANGPTL3

27329

Q9Y5C1

0.52

CAPN1

823

P07384

0.55

P2RY2

5029

P41231

0.55

SRC

6714

P12931

0.55

TGM2

7052

P21980

0.55

THY1

7070

P04216

0.55

YES1

7525

P07947

0.56

DAB1

1600

O75553

0.59

DAB2

1601

P98082

0.59

DOK1

1796

Q99704

0.59

EPS8

2059

Q12929

0.59

NUMB

8650

P49757

0.59

TNS2

23371

Q63HR2

0.59

FLNA

2316

P21333

0.63

FLNB

2317

O75369

0.63

LYN

4067

P07948

0.68

CD36

948

P16671

0.73

ILK

3611

Q13418

0.73

PDGFRA

5156

P16234

0.74

PXN

5829

P49023

0.75

PTK2B

2185

Q14289

0.76

THBS1

7057

P07996

0.87

ITGB3BP

23421

Q13352

0.87

PTK2

5747

Q05397

0.89

ITGA2B

3674

P08514

0.90

ITGAV

3685

P06756

0.90

TLN1

7094

Q9Y490

0.97